TechCrunch LA

MARCH 20, 2019

The feature illustrates how Postmates, one of the earlier entrants to the billion-dollar food delivery wars , is trying to remain competitive by appealing to price-sensitive customers. Los Angeles, Miami, New York City, Phoenix, San Francisco, San Diego, Seattle, Orange County, Calif. and Philadelphia.

Orange County 200

Orange County Long Beach San Diego Los Angeles 200

TechCrunch LA

DECEMBER 8, 2020

He did note that in the four markets where the company has gone live since launching its business in January 2019 — San Diego, Los Angeles, the Inland Empire , and Sacramento — has yielded an annualized revenue run rate of over $400 million in gross merchandise value (the total value of home sales transacted on its platform).

Sales 282

Sales Demand San Diego Funding 282

socalTECH

MAY 8, 2015

In a world awash with on-demand startups, Los Angeles-based Serviz (www.serviz.com) stands out--not because of the market segment it is tackling, but because it was founded by two, very experienced serial entrepreneurs-- Zorik Gordon and Michael Kline. Our vision is really to become the premier provider of on-demand home services.

Services 100

Services ReachLocal Demand Startup 100

socalTECH

APRIL 26, 2017

Eugene Cho is CEO of San Diego-based Echo Laboratories (www.discover-echo.com), a startup which is developing a new kind of microscope. We've created an alternative, a hybrid microscope for the price of one. We got first place in that competition, and they followed up with a $2M investment in the form of a convertible note.

Tech Coast Angels 124

Tech Coast Angels Startup Sales Slides 124

socalTECH

APRIL 26, 2017

Eugene Cho is CEO of San Diego-based Echo (www.discover-echo.com), a startup which is developing a new kind of microscope. We've created an alternative, a hybrid microscope for the price of one. We got first place in that competition, and they followed up with a $2M investment in the form of a convertible note.

Tech Coast Angels 100

Tech Coast Angels Startup Sales Slides 100

Xconomy

AUGUST 16, 2016

The industry can only go so far with growth through hyper-inflated pricing and mega-M&As. At some point pharma has to figure out how to make more drugs more efficiently, or face major dislocations like business-destroying price controls. The increasing need for new drugs is intense.

Product 40

Product Journal Venture Capital Demand 40